KR860000841B1 - 시스프라틴의 안정화된 농축용액의 제조방법 - Google Patents
시스프라틴의 안정화된 농축용액의 제조방법 Download PDFInfo
- Publication number
- KR860000841B1 KR860000841B1 KR1019810001029A KR810001029A KR860000841B1 KR 860000841 B1 KR860000841 B1 KR 860000841B1 KR 1019810001029 A KR1019810001029 A KR 1019810001029A KR 810001029 A KR810001029 A KR 810001029A KR 860000841 B1 KR860000841 B1 KR 860000841B1
- Authority
- KR
- South Korea
- Prior art keywords
- cisplatin
- solution
- polyethylene glycol
- platinum
- room temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13537380A | 1980-03-31 | 1980-03-31 | |
US135373 | 1980-03-31 | ||
US135.373 | 1980-03-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR830004849A KR830004849A (ko) | 1983-07-20 |
KR860000841B1 true KR860000841B1 (ko) | 1986-07-09 |
Family
ID=22467813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019810001029A Expired KR860000841B1 (ko) | 1980-03-31 | 1981-03-28 | 시스프라틴의 안정화된 농축용액의 제조방법 |
Country Status (30)
Country | Link |
---|---|
JP (1) | JPS56152415A (es) |
KR (1) | KR860000841B1 (es) |
AR (1) | AR225500A1 (es) |
AT (1) | AT370996B (es) |
AU (1) | AU541056B2 (es) |
BE (1) | BE888209A (es) |
CA (1) | CA1162479A (es) |
CH (1) | CH647481A5 (es) |
CS (1) | CS246051B2 (es) |
DD (1) | DD157762A5 (es) |
DE (1) | DE3112272A1 (es) |
DK (1) | DK158564C (es) |
ES (1) | ES500869A0 (es) |
FI (1) | FI70670C (es) |
FR (1) | FR2480605A1 (es) |
GB (1) | GB2074028B (es) |
GR (1) | GR72769B (es) |
HU (1) | HU183379B (es) |
IE (1) | IE51070B1 (es) |
IL (1) | IL62517A (es) |
IT (1) | IT1170838B (es) |
LU (1) | LU83270A1 (es) |
NL (1) | NL8101531A (es) |
NO (1) | NO156675C (es) |
NZ (1) | NZ196519A (es) |
PH (1) | PH17152A (es) |
PT (1) | PT72774B (es) |
SE (1) | SE455045B (es) |
SU (1) | SU1056893A3 (es) |
ZA (1) | ZA812084B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
NL8303657A (nl) * | 1983-10-24 | 1985-05-17 | Pharmachemie Bv | Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan. |
FI895340A7 (fi) * | 1988-11-14 | 1990-05-15 | Bristol Myers Squibb Co | Hypertoninen cisplatin-liuos |
JP2001501173A (ja) * | 1996-08-23 | 2001-01-30 | アルザ コーポレイション | シスプラチン化合物を含有するリポソーム |
AUPQ641100A0 (en) | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
JP4445304B2 (ja) | 2004-03-26 | 2010-04-07 | オンキヨー株式会社 | スイッチングアンプ |
US8852566B2 (en) * | 2009-03-26 | 2014-10-07 | Warsaw Orthopedic, Inc. | Compositions and methods for preferential distribution of active agents to injury sites |
WO2019185859A1 (en) | 2018-03-29 | 2019-10-03 | Project Pharmaceutics Gmbh | Liquid pharmaceutical formulation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4177263A (en) * | 1972-02-28 | 1979-12-04 | Research Corporation | Anti-animal tumor method |
CA1119954A (en) * | 1978-05-30 | 1982-03-16 | Edmund S. Granatek | Aqueous solution of cisplatin |
-
1981
- 1981-03-06 AU AU68166/81A patent/AU541056B2/en not_active Ceased
- 1981-03-06 CA CA000372499A patent/CA1162479A/en not_active Expired
- 1981-03-17 NZ NZ196519A patent/NZ196519A/xx unknown
- 1981-03-24 IT IT48090/81A patent/IT1170838B/it active
- 1981-03-24 FR FR8105848A patent/FR2480605A1/fr active Granted
- 1981-03-25 CH CH2023/81A patent/CH647481A5/fr not_active IP Right Cessation
- 1981-03-26 FI FI810934A patent/FI70670C/fi not_active IP Right Cessation
- 1981-03-26 GR GR64497A patent/GR72769B/el unknown
- 1981-03-27 PH PH25435A patent/PH17152A/en unknown
- 1981-03-27 DE DE19813112272 patent/DE3112272A1/de active Granted
- 1981-03-27 NL NL8101531A patent/NL8101531A/nl not_active Application Discontinuation
- 1981-03-27 ZA ZA00812084A patent/ZA812084B/xx unknown
- 1981-03-27 SE SE8101990A patent/SE455045B/sv not_active IP Right Cessation
- 1981-03-28 KR KR1019810001029A patent/KR860000841B1/ko not_active Expired
- 1981-03-30 IE IE715/81A patent/IE51070B1/en not_active IP Right Cessation
- 1981-03-30 AR AR284799A patent/AR225500A1/es active
- 1981-03-30 NO NO811081A patent/NO156675C/no unknown
- 1981-03-30 DK DK144281A patent/DK158564C/da not_active IP Right Cessation
- 1981-03-30 JP JP4569081A patent/JPS56152415A/ja active Granted
- 1981-03-30 IL IL62517A patent/IL62517A/xx unknown
- 1981-03-30 PT PT72774A patent/PT72774B/pt not_active IP Right Cessation
- 1981-03-30 SU SU813265697A patent/SU1056893A3/ru active
- 1981-03-30 GB GB8109926A patent/GB2074028B/en not_active Expired
- 1981-03-30 HU HU81811A patent/HU183379B/hu not_active IP Right Cessation
- 1981-03-30 ES ES500869A patent/ES500869A0/es active Granted
- 1981-03-31 CS CS812390A patent/CS246051B2/cs unknown
- 1981-03-31 DD DD81228776A patent/DD157762A5/de not_active IP Right Cessation
- 1981-03-31 LU LU83270A patent/LU83270A1/fr unknown
- 1981-03-31 BE BE0/204323A patent/BE888209A/fr not_active IP Right Cessation
- 1981-03-31 AT AT0150481A patent/AT370996B/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4451447A (en) | Pharmaceutical formulations | |
JP3547755B2 (ja) | オキサリプラティヌムの医薬的に安定な製剤 | |
US4322391A (en) | Process for the preparation of microcrystalline cisplatin | |
FI78236C (fi) | Foerfarande foer framstaellning av en frystorkad doseringsenhet av cis-platina (ii) diamindiklorid. | |
KR100351713B1 (ko) | 백금(ii) 항종양제의 안정용액 | |
KR20010041182A (ko) | 배합물 | |
KR860000841B1 (ko) | 시스프라틴의 안정화된 농축용액의 제조방법 | |
JPS62103020A (ja) | 難溶性薬物の可溶化組成物 | |
KR970000507B1 (ko) | 안정된 안트라사이클린 제제 | |
HU177557B (en) | Process for preparing stable aequous sterile solution of cys-platinic/ii/-diamine-dichloride | |
EP0659435B1 (en) | Injectable ready-to-use solutions containing Doxorubicin | |
PT93991B (pt) | Processo para a preparacao de solucoes estaveis de analogos de rebecamicina | |
DK159376B (da) | Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid | |
JPH01305030A (ja) | トラコーマクラミジア感染症の単一筋肉内投与による治療用の組成物 | |
CA2486571C (en) | Pharmaceutical composition | |
US4946689A (en) | Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin | |
US6060498A (en) | Composition containing antitumor agent | |
AU623632B2 (en) | A solution of carboplatin | |
FI72302C (fi) | Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin. | |
KR830000525B1 (ko) | 주사용 아세틸 살리실레이트 분말제의 안정화 방법 | |
JPS63174928A (ja) | 注射用製剤 | |
IE51468B1 (en) | Microcrystalline cisplatin and formulations containing it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
PG1605 | Publication of application before grant of patent |
St.27 status event code: A-2-2-Q10-Q13-nap-PG1605 |
|
PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 19930710 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 19930710 |
|
R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |
|
R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |